54322-29-1Relevant academic research and scientific papers
BRANCHED TAIL LIPID COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS
-
Paragraph 00335; 00416; 00422, (2021/04/01)
The application relates to lipids of Formula (A), Formula (B) and Formula (1-1), and to lipid nanoparticles (empty or loaded LNPs) including such a lipid as well as additional lipids such as phospholipids, structural lipids, and PEG lipids. Lipid nanoparticles further including therapeutic and/or prophylactics such as RNA are useful in the delivery of therapeutic and/or prophylactics to mammalian cells or organs to, for example, regulate polypeptide, protein, or gene expression.
Asymmetric alkene cycloalumination by AlEt3, catalyzed with neomenthylindenyl zirconium η5-complexes
Parfenova, Lyudmila V.,Kovyazin, Pavel V.,Tyumkina, Tatyana V.,Berestova, Tatyana V.,Khalilov, Leonard M.,Dzhemilev, Usein M.
, p. 19 - 25 (2013/02/21)
The paper is devoted to a study of the reaction of terminal alkene cycloalumination by AlEt3 catalyzed with neomenthylindenyl zirconium complexes (p-S)(p-S)-bis[η5-[1-[(1S,2S,5R)-2-isopropyl-5- methylcycloh-exyl]indenyl]]zirconium dichloride (1) or (p-S)-(η5- cyclopentadienyl)[η5-[1-[(1S,2S,5R)-2-isopropyl-5- methylcyclohexyl]indenyl]]zirconium dichloride (2). It was shown that alkene and catalyst structures, as well as solvent, affect the overall yield and enantiomeric excess of the reaction product - 3-alkylsubstituted aluminacyclopentanes. The reaction of terminal alkenes with AlEt3, catalyzed by complex 1, in hydrocarbon solvents gives predominantly S-enantiomers of cyclic organoaluminum compounds with enantiomeric excess up to 37%. Complex 2 shows smaller stereoinduction effect and provides R-enantiomers of aluminacyclopentanes with 6-26%ee. The effectiveness of selenium-containing derivatizing reagent (R)-2-phenylselenopropanoic acid for the enantiomeric excess estimation in β-alkyl-1,4-butanediols obtained from cyclic organoaluminum compounds was shown.
Tandem hydroformylation/hydrogenation of alkenes to normal alcohols using Rh/Ru dual catalyst or Ru single component catalyst
Takahashi, Kohei,Yamashita, Makoto,Nozaki, Kyoko
supporting information, p. 18746 - 18757 (2013/01/15)
The catalyst system for tandem hydroformylation/hydrogenation of terminal alkenes to the corresponding homologated normal alcohol was developed. The reaction mechanism for the Rh/Ru dual catalyst was investigated by real-time IR monitoring experiments and 31P NMR spectroscopy, which proved the mutual orthogonality of Rh-catalyzed hydroformylation and Ru-catalyzed hydrogenation. Detailed investigation about Ru-catalyzed hydrogenation of undecanal under H2/CO pressure clarified different kinetics from the hydrogenation under H2 and gave a clue to design more active hydrogenation catalysts under H2/CO atmosphere. The solely Ru-catalyzed normal selective hydroformylation/hydrogenation is also reported.
An effect of application of chiral aluminium alkoxides and amides as adducts to zirconium catalyzed carbo- and cycloalumination of olefins
Khalilov, Leonard M.,Parfenova, Ludmila V.,Pechatkina, Svetlana V.,Ibragimov, Askhat G.,Genet, Jean P.,Dzhemilev, Usein M.,Beletskaya, Irina P.
, p. 444 - 453 (2007/10/03)
This paper is dedicated to a study of properties of the following novel optically active organoaluminium compounds (OACs): (1S,2S)-l,7,7-trimethyl-2-[(dialkylalumina)oxy]-bicyclo[2.2.1]heptanes and (1S)-N-(dialkylalumina)-6,7-dimethoxy-1-methyl-1,2,3,4 -tetrahydroisoquinolines. The synthesis of the chiral OACs was carried out in the reaction of either natural camphor or salsolidine with both AlEt3 and i-Bu2AlH. The main goal of the research was to investigate the stereodifferentiating activity of the chiral OACs in the olefin carbo- and cycloalumination reactions, catalyzed by Cp2ZrCl2.
